{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:37:49Z","timestamp":1788629869698,"version":"build-2803163510"},"reference-count":155,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015826","name":"Korean Society of Ginseng","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ginseng Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgr.2026.101073","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:22:21Z","timestamp":1780586541000},"page":"101073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ginsenosides Rh2 and Rg3 in first-line combination therapy: Prospects for rapid clinical translation in drug-resistant triple-negative breast cancer"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9301-6313","authenticated-orcid":false,"given":"Sungpil","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8141-9927","authenticated-orcid":false,"given":"Jae Youl","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgr.2026.101073_bib1","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jgr.2026.101073_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jgr.2026.101073_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70803","article-title":"Targeting triple-negative breast cancer: resistance mechanisms and therapeutic advancements","volume":"14","author":"Raman","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.jgr.2026.101073_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101288","article-title":"Drug resistance in breast cancer: mechanisms and strategies for management","volume":"83","author":"Wu","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jgr.2026.101073_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1666126","article-title":"Research progress of molecular typing and targeted therapy for triple-negative breast cancer","volume":"15","author":"Xiang","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.jgr.2026.101073_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00432-022-04387-2","article-title":"Role of natural P-gp inhibitor in the effective delivery for chemotherapeutic agents","volume":"149","author":"Shah","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jgr.2026.101073_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.21873\/anticanres.16900","article-title":"Co-treatment with aripiprazole and vincristine sensitizes P-Glycoprotein-Overexpressing Drug-resistant MCF-7\/ADR breast cancer cells","volume":"44","author":"Shin","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jgr.2026.101073_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jgr.2024.01.001","article-title":"Ginseng root-derived exosome-like nanoparticles protect skin from UV irradiation and oxidative stress by suppressing activator protein-1 signaling and limiting the generation of reactive oxygen species","volume":"48","author":"Choi","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jgr.2024.08.003","article-title":"Ethanol extract of lymphanax with gypenoside 17 and ginsenoside re exerts anti-inflammatory properties by targeting the AKT\/NF-kappaB pathway","volume":"49","author":"Choi","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jgr.2025.04.004","article-title":"Therapeutic potential of ginsenosides in circadian rhythm-based skin disorders","volume":"49","author":"Ha","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062593","article-title":"Anti-Colorectal cancer activity of panax and its active components, ginsenosides: a review","volume":"26","author":"Kang","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgr.2026.101073_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jgr.2025.03.012","article-title":"Protopanaxatriol, a ginsenoside metabolite, induces apoptosis in colorectal cancer cells and arrests their cell cycle by targeting AKT","volume":"49","author":"Wang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jgr.2025.08.010","article-title":"Immunomodulatory effects of the combination of Korean red ginseng and Cervi Parvum Cornu via the MAPK pathway","volume":"49","author":"Chen","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jgr.2025.09.004","article-title":"Korean red ginseng extract suppresses food allergy by remodeling the gut microbiota and restoring immune homeostasis in IL4ra(F709) mice","volume":"49","author":"Choi","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jgr.2025.02.002","article-title":"Korean black ginseng extract alleviates Alzheimer's disease-related cognitive impairment by activating the Nrf2\/HO-1 pathway and suppressing the p38 MAPK\/NF-kappaB\/STAT3 pathways and NLRP3 inflammasome via TLR2 and TLR4 modulation","volume":"49","author":"Ha","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jgr.2024.12.004","article-title":"Antiviral potential of ginseng: targeting human pathogenic viruses with compounds derived from ginseng","volume":"49","author":"Huo","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jgr.2025.03.011","article-title":"Panax ginseng: a modulator of amyloid, tau pathology, and cognitive function in Alzheimer's disease","volume":"49","author":"Hwang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jgr.2024.04.005","article-title":"Ginseng as a therapeutic target to alleviate gut and brain diseases via microbiome regulation","volume":"49","author":"Iqbal","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jgr.2025.05.005","article-title":"The role of ginseng in aging: insights into regulatory T cells activation and mitochondrial regulation","volume":"49","author":"Iqbal","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jgr.2024.08.001","article-title":"Korean Red Ginseng alleviates dextran sodium sulfate-induced colitis through gut microbiota modulation in mice","volume":"48","author":"Jeong","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jgr.2025.04.003","article-title":"Korean Red ginseng supplements improve quality of life in patients with mild chronic pancreatitis symptoms: a prospective clinical trial","volume":"49","author":"Kang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jgr.2024.06.002","article-title":"The effects of Panax ginseng on growth enhancement, innate immunity, and microbiome profiling in Penaeus vannamei","volume":"48","author":"Kim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jgr.2025.06.001","article-title":"A comprehensive review of the effects of Panax ginseng and its constituents against inflammatory diseases","volume":"49","author":"Kim","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jgr.2024.11.004","article-title":"Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2","volume":"49","author":"Kim","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jgr.2025.05.004","article-title":"Red ginseng extract enhances mitochondrial function and alleviates immunosenescence in T cells","volume":"49","author":"Lee","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jgr.2025.09.003","article-title":"Panax ginseng alleviates diabetic peripheral neuropathy by suppressing mitochondrial dysfunction and oxidative stress via modulation of the RAGE, NF-kappaB, and Nrf2 pathways","volume":"49","author":"Liu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jgr.2024.10.001","article-title":"Effects of Korean red ginseng on auditory, cognitive, and liver functions in a naturally aged mouse model","volume":"49","author":"Shin","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jgr.2025.01.001","article-title":"Panax ginseng exerts cardioprotective effect post myocardial infarction by attenuating myocardial fibrosis and inflammation through SIRT1 signaling pathways","volume":"49","author":"Xu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jgr.2025.08.001","article-title":"Pyroptosis: a pharmacological target of ginseng and its phytochemical components for human inflammatory diseases","volume":"49","author":"Yi","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jgr.2024.09.008","article-title":"Maltol, a compound in Korean Red Ginseng, attenuates the Staphylococcus aureus-induced inflammasome activation in the skin","volume":"48","author":"Ahn","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jgr.2023.12.001","article-title":"Gintonin upregulates cytokine production and expression of NKp30, NKp44 and NKp44 related to natural killer cell activity on immunosuppressive rat","volume":"48","author":"Chen","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgr.2024.09.005","article-title":"Non-saponin from Panax ginseng maintains blood-brain barrier integrity by inhibiting NF-kappaB and p38 MAP kinase signaling pathways to prevent the progression of experimental autoimmune encephalomyelitis","volume":"49","author":"Oh","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jgr.2024.04.003","article-title":"Effects of Panax species and their bioactive components on allergic airway diseases","volume":"48","author":"Shim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jgr.2022.09.011","article-title":"The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo","volume":"47","author":"Hu","year":"2023","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jgr.2025.05.003","article-title":"In vivo metabolism, pharmacokinetics, and pharmacological activities of ginsenosides from ginseng","volume":"49","author":"Wang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jgr.2021.12.007","article-title":"Ginsenosides are active ingredients in Panax ginseng with immunomodulatory properties from cellular to organismal levels","volume":"46","author":"You","year":"2022","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13020-023-00822-9","article-title":"Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer","volume":"18","author":"Jiang","year":"2023","journal-title":"Chin Med"},{"key":"10.1016\/j.jgr.2026.101073_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jgr.2025.04.002","article-title":"Ginsenoside Rg5 inhibits platelet aggregation by regulating GPVI signaling pathways and ferric chloride-induced thrombosis","volume":"49","author":"Akram","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jgr.2025.06.003","article-title":"Ginsenoside Rb1 ameliorates post-doxorubicin treatment myocardial hypertrophy via CaN\/NFATc4\/GATA4","volume":"49","author":"Chang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib40","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jgr.2025.06.004","article-title":"Ginsenoside Rg5 enhances Abemaciclib sensitivity in ER+ breast cancer by modulating cell cycle proteins via transcriptional and post-translational levels","volume":"49","author":"Chen","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jgr.2025.05.007","article-title":"Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression","volume":"49","author":"Deng","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgr.2025.10.003","article-title":"Ginsenoside Rb1-enhanced decellularized extracellular matrix hydrogels ameliorates mitochondrial dysfunction and cellular aging in sepsis-induced acute lung injury","volume":"50","author":"Gao","year":"2026","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jgr.2025.05.001","article-title":"Total ginsenosides and ginsenoside Rb2 delay hepatocyte senescence by regulating NAD(+) metabolism and promoting IDO2\/QPRT expression","volume":"49","author":"Guo","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jgr.2025.01.002","article-title":"The molecular mechanism of ginsenoside Rh2 and its octyl ester derivative on anti-angiogenesis in cancer treatment: the battle between PI3K and ROS","volume":"49","author":"Hu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jgr.2023.06.001","article-title":"Rg3-enriched red ginseng extracts enhance apoptosis in CoCl(2)-stimulated breast cancer cells by suppressing autophagy","volume":"48","author":"Jeong","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jgr.2024.12.002","article-title":"Ginsenoside Rg1 exerts antidepressant effect by regulating hepatic kynurenine metabolism through promoting the interaction between HNF4alpha and PGC1alpha","volume":"49","author":"Jia","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jgr.2022.05.002","article-title":"Ginsenoside Rg1 promotes neurite growth of retinal ganglion cells through cAMP\/PKA\/CREB pathways","volume":"48","author":"Jiang","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib48","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jgr.2025.03.004","article-title":"Compound K suppresses epidermal aging induced by IL-17A treatment and UVB irradiation","volume":"49","author":"Kim","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jgr.2024.01.006","article-title":"Ginsenoside Rg5, a potent agonist of Nrf2, inhibits HSV-1 infection-induced neuroinflammation by inhibiting oxidative stress and NF-kappaB activation","volume":"48","author":"Kim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jgr.2023.10.001","article-title":"Ginsenoside F2 restrains hepatic steatosis and inflammation by altering the binding affinity of liver X receptor coregulators","volume":"48","author":"Kim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jgr.2024.03.002","article-title":"Ginsenosides for the treatment of insulin resistance and diabetes: therapeutic perspectives and mechanistic insights","volume":"48","author":"Kim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jgr.2024.05.006","article-title":"Effect of ginseng and ginsenosides on attention deficit hyperactivity disorder: a systematic review","volume":"48","author":"Kim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgr.2025.11.007","article-title":"Ginsenoside Rg1 attenuates asthma features in mice co-exposed to house dust mite allergen and diesel exhaust particle by modulating epithelial ILC2 interactions","volume":"50","author":"Lee","year":"2026","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgr.2025.10.006","article-title":"Ginsenoside Rg3-enriched red ginseng extract mitigates sepsis by inhibiting platelet-leukocyte aggregates and regulates thrombo-inflammatory pathways","volume":"50","author":"Lee","year":"2026","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jgr.2024.07.002","article-title":"20(S)-Ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src\/STAT3 signaling","volume":"48","author":"Li","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgr.2025.11.009","article-title":"Ginsenoside Rg5 mitigates tenocyte death via SIRT6\/autophagy-dependent signaling in an aging model","volume":"50","author":"Lim","year":"2026","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgr.2025.10.008","article-title":"Ginsenoside re mitigates Abeta(1-42)-induced neurotoxicity by promoting autophagy and suppressing NLRP3 inflammasome","volume":"50","author":"Madhi","year":"2026","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jgr.2024.11.003","article-title":"Synergistic effects of ginsenoside Rb1 and peroxiredoxin 6 in enhancing myocardial injury treatment through anti-inflammatory, anti-oxidative, and anti-apoptotic mechanisms","volume":"49","author":"Mu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jgr.2021.05.008","article-title":"Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3","volume":"48","author":"Nakhjavani","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jgr.2025.04.006","article-title":"Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model","volume":"49","author":"Pu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jgr.2024.03.001","article-title":"Ginsenoside Rg1 alleviates vascular remodeling in hypoxia-induced pulmonary hypertension mice through the calpain-1\/STAT3 signaling pathway","volume":"48","author":"Ran","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jgr.2023.11.004","article-title":"The pharmacological role of Ginsenoside Rg3 in liver diseases: a review on molecular mechanisms","volume":"48","author":"Wang","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jgr.2023.09.002","article-title":"Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA\/TNFAR and IL7\/IL7R signaling between macrophages and epithelial cells","volume":"48","author":"Wang","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jgr.2024.05.002","article-title":"The necessity of eliminating the interference of panaxatriol saponins to maximize the preventive effect of panaxadiol saponins against Parkinson's disease in rats","volume":"48","author":"Wang","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jgr.2025.03.008","article-title":"Ginsenoside Rh2 alleviates inflammatory response and enhances motor function recovery in spinal cord injury mice via the ROS\/MAPK14 signaling pathway","volume":"49","author":"Wu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib66","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jgr.2025.07.003","article-title":"Ginsenoside Rc mitigates hippocampal neuronal damage and cognitive impairment in vascular dementia rats via the pY705-Stat3\/Foxo3a and pS727-Stat3\/GRIM-19 pathways","volume":"49","author":"Wu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib67","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jgr.2024.07.003","article-title":"Ginsenoside Rg1 reduces cardiac inflammation against myocardial ischemia\/reperfusion injury by inhibiting macrophage polarization","volume":"48","author":"Xu","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib68","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jgr.2025.02.001","article-title":"Ginsenoside Rg2, a principal effective ingredient of Panax ginseng, attenuates DSS-induced ulcerative colitis through NF-kappaB\/NLRP3 pathway","volume":"49","author":"Zhang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jgr.2025.02.003","article-title":"Roles and mechanisms of ginsenoside Rg1 in coronary artery disease: progress and perspectives","volume":"49","author":"Zhang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib70","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jgr.2023.06.008","article-title":"Ginsenoside 20(S)-Rg3 reduces KIF20A expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer","volume":"48","author":"Zhang","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib71","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jgr.2024.10.002","article-title":"Ginsenoside Rg1 improves hypoxia-induced pulmonary vascular endothelial dysfunction through TXNIP\/NLRP3 pathway-modulated mitophagy","volume":"49","author":"Zhang","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jgr.2025.06.002","article-title":"Ginsenoside Rb1 attenuates age-associated cognitive impairment by modulating oxidative stress and the SIRT1\/eNOS\/NO axis","volume":"49","author":"Zhou","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib73","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jgr.2024.03.003","article-title":"Ginseng-derived compounds as potential anticancer agents targeting cancer stem cells","volume":"48","author":"Lee","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154938","article-title":"Ginsenoside Rh2: a shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future","volume":"118","author":"Guan","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101073_bib75","article-title":"Ginsenoside Rg3: potential molecular targets and therapeutic indication in metastatic breast cancer","volume":"6","author":"Nakhjavani","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.jgr.2026.101073_bib76","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.21873\/invivo.12936","article-title":"Combination treatment using pyruvate kinase M2 inhibitors for the sensitization of high density triple-negative breast cancer cells","volume":"36","author":"Lee","year":"2022","journal-title":"In vivo"},{"key":"10.1016\/j.jgr.2026.101073_bib77","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2174\/1570163817666200518081955","article-title":"Targeting different pathways using novel combination therapy in triple negative breast cancer","volume":"20","author":"Mir","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jgr.2026.101073_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4062\/biomolther.2024.069","article-title":"Low-Dose perifosine, a phase II phospholipid Akt Inhibitor, selectively sensitizes drug-resistant ABCB1-Overexpressing cancer cells","volume":"33","author":"Park","year":"2025","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.jgr.2026.101073_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098389","article-title":"First-Line combination treatment with low-dose bipolar drugs for ABCB1-Overexpressing drug-resistant cancer populations","volume":"24","author":"Yoon","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgr.2026.101073_bib80","first-page":"4139","article-title":"Highly eribulin-resistant KBV20C oral cancer cells can be sensitized by Co-treatment with the third-generation P-Glycoprotein inhibitor, elacridar, at a low dose","volume":"37","author":"Park","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jgr.2026.101073_bib81","doi-asserted-by":"crossref","first-page":"177","DOI":"10.15430\/JCP.2013.18.2.177","article-title":"Ginsenoside Rg3 induces apoptosis of human breast cancer (MDA-MB-231) cells","volume":"18","author":"Kim","year":"2013","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.jgr.2026.101073_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15430\/JCP.2014.19.1.23","article-title":"Ginsenoside Rg3 inhibits constitutive activation of NF-kappaB signaling in human breast cancer (MDA-MB-231) cells: ERK and Akt as potential upstream targets","volume":"19","author":"Kim","year":"2014","journal-title":"J Cancer Prev"},{"key":"10.1016\/j.jgr.2026.101073_bib83","first-page":"2889","article-title":"Phosphoproteomic analysis of the antitumor effects of ginsenoside Rg3 in human breast cancer cells","volume":"15","author":"Zou","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jgr.2026.101073_bib84","doi-asserted-by":"crossref","first-page":"601","DOI":"10.62347\/GYXE7741","article-title":"Ginsenoside Rg3 decreases breast cancer stem-like phenotypes through impairing MYC mRNA stability","volume":"14","author":"Ning","year":"2024","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jgr.2026.101073_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117158","article-title":"Ginsenoside Rg3 attenuates the stemness of breast cancer stem cells by activating the hippo signaling pathway","volume":"494","author":"Deng","year":"2025","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jgr.2018.05.004","article-title":"The standardized Korean Red Ginseng extract and its ingredient ginsenoside Rg3 inhibit manifestation of breast cancer stem cell-like properties through modulation of self-renewal signaling","volume":"43","author":"Oh","year":"2019","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jgr.2026.101073_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ph12030117","article-title":"Stereoselective anti-cancer activities of ginsenoside Rg3 on triple negative breast cancer cell models","volume":"12","author":"Nakhjavani","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jgr.2026.101073_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ph14070633","article-title":"Anti-Cancer effects of an optimised combination of ginsenoside Rg3 epimers on triple negative breast cancer models","volume":"14","author":"Nakhjavani","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jgr.2026.101073_bib89","first-page":"291","article-title":"Co-treatment with ginsenoside 20(S)-Rg3 and curcumin increases radiosensitivity of MDA-MB-231 cancer cell line","volume":"46","author":"Changizi","year":"2021","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.jgr.2026.101073_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biopha.2017.02.038","article-title":"Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-kappaB signaling and regulating Bax\/Bcl-2 expression on triple-negative breast cancer","volume":"89","author":"Yuan","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jgr.2026.101073_bib91","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12951-022-01623-2","article-title":"Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes","volume":"20","author":"Xia","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jgr.2026.101073_bib92","first-page":"3472","article-title":"[Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer]","volume":"48","author":"Liu","year":"2023","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.jgr.2026.101073_bib93","article-title":"Multifunctional biomimetic liposomes with improved tumor-targeting for TNBC treatment by combination of chemotherapy, antiangiogenesis and immunotherapy","volume":"13","author":"Lan","year":"2024","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jgr.2026.101073_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03639045.2023.2188078","article-title":"Ginsenoside Rg3 liposomes regulate tumor microenvironment for the treatment of triple negative breast cancer","volume":"49","author":"Miao","year":"2023","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jgr.2026.101073_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112274","article-title":"Simultaneous co-delivery of Ginsenoside Rg3 and imiquimod from PLGA nanoparticles for effective breast cancer immunotherapy","volume":"28","author":"Hu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jgr.2026.101073_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156514","article-title":"Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer","volume":"139","author":"Huang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101073_bib97","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40824-022-00329-8","article-title":"Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti-cancer evaluation of peritumoral hydrogel injection combined with PD-L1 antibody","volume":"26","author":"Wu","year":"2022","journal-title":"Biomater Res"},{"key":"10.1016\/j.jgr.2026.101073_bib98","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12951-024-02677-0","article-title":"A pH-triggered N-oxide polyzwitterionic nano-drug loaded system for the anti-tumor immunity activation research","volume":"22","author":"Zhao","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jgr.2026.101073_bib99","doi-asserted-by":"crossref","first-page":"17177","DOI":"10.18632\/aging.203131","article-title":"Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1\/PD-L1 pathway in triple-negative breast cancer","volume":"13","author":"Luo","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jgr.2026.101073_bib100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/jcb.22932","article-title":"Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models","volume":"112","author":"Choi","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jgr.2026.101073_bib101","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s11095-009-9944-9","article-title":"Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclin-dependent kinases","volume":"26","author":"Choi","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.jgr.2026.101073_bib102","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1476-5381.2010.00768.x","article-title":"Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt","volume":"160","author":"Park","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib103","article-title":"Ginsenoside Rh2 regulates triple-negative breast cancer proliferation and apoptosis via the IL-6\/JAK2\/STAT3 pathway","volume":"15","author":"Ding","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155180","article-title":"Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer","volume":"123","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101073_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/biom10040528","article-title":"(20S)G-Rh2 inhibits NF-kappaB regulated epithelial-mesenchymal transition by targeting annexin A2","volume":"10","author":"Wang","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jgr.2026.101073_bib106","article-title":"The identification of molecular target of (20S) ginsenoside Rh2 for its anti-cancer activity","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgr.2026.101073_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111422","article-title":"The novel ginseng Rh2 derivative 2-deoxy-Rh2, exhibits potent anticancer effect via the AMPK\/mTOR\/autophagy signaling pathway against breast cancer","volume":"409","author":"Li","year":"2025","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jgr.2026.101073_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23112908","article-title":"Antiproliferative activity of combined biochanin A and ginsenoside Rh(2) on MDA-MB-231 and MCF-7 human breast cancer cells","volume":"23","author":"Ren","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jgr.2026.101073_bib109","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/acs.bioconjchem.3c00207","article-title":"EGFR-Targeted liposomes combined with ginsenoside Rh2 inhibit triple-negative breast cancer growth and metastasis","volume":"34","author":"Gu","year":"2023","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.jgr.2026.101073_bib110","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.2147\/IJN.S448860","article-title":"The remarkable anti-breast cancer efficacy and anti-metastasis by multifunctional nanoparticles Co-Loading squamocin, R848 and IR 780","volume":"19","author":"Wang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jgr.2026.101073_bib111","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-2952(02)01446-6","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3)","volume":"65","author":"Kim","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib112","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12272-001-1137-y","article-title":"Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation","volume":"31","author":"Kwon","year":"2008","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.jgr.2026.101073_bib113","first-page":"4376","article-title":"Treatment with 20(S)-ginsenoside Rg3 reverses multidrug resistance in A549\/DDP xenograft tumors","volume":"15","author":"Liu","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jgr.2026.101073_bib114","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/bdd.1806","article-title":"Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo","volume":"33","author":"Yang","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.jgr.2026.101073_bib115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2022.09.007","article-title":"Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells","volume":"49","author":"Zhu","year":"2023","journal-title":"J Adv Res"},{"key":"10.1016\/j.jgr.2026.101073_bib116","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1002\/fsn3.4205","article-title":"Ginsenoside Rg3 combined with near-infrared photothermal reversal of multidrug resistance in breast cancer MCF-7\/ADR cells","volume":"12","author":"Chang","year":"2024","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.jgr.2026.101073_bib117","first-page":"630","article-title":"Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism","volume":"18","author":"Ma","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jgr.2026.101073_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101452","article-title":"Ginsenoside Rh2 pretreatment and withdrawal reactivated the pentose phosphate pathway to ameliorate intracellular redox disturbance and promoted intratumoral penetration of adriamycin","volume":"32","author":"Liu","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.jgr.2026.101073_bib119","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s13346-017-0402-7","article-title":"Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2","volume":"7","author":"Yang","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jgr.2026.101073_bib120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13577-017-0189-3","article-title":"The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism","volume":"31","author":"Liu","year":"2018","journal-title":"Hum Cell"},{"key":"10.1016\/j.jgr.2026.101073_bib121","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jare.2024.09.006","article-title":"20(S)-Ginsenoside Rh2 overcomes gemcitabine resistance in pancreatic cancer by inhibiting LAMC2-Modulated ABC transporters","volume":"73","author":"Wu","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.jgr.2026.101073_bib122","article-title":"Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jgr.2026.101073_bib123","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1476-5381.2011.01505.x","article-title":"Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7\/Adr cells","volume":"165","author":"Zhang","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib124","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1124\/dmd.110.034793","article-title":"20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo: a case for herb-drug interactions","volume":"38","author":"Zhang","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgr.2026.101073_bib125","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1124\/dmd.112.045187","article-title":"Key role of nuclear factor-kappaB in the cellular pharmacokinetics of adriamycin in MCF-7\/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2","volume":"40","author":"Zhang","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgr.2026.101073_bib126","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1124\/dmd.111.040006","article-title":"Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms","volume":"39","author":"Yang","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jgr.2026.101073_bib127","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1021\/acs.biomac.7b00011","article-title":"Oral nanomedicine based on multicomponent microemulsions for drug-resistant breast cancer treatment","volume":"18","author":"Qu","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jgr.2026.101073_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123718","article-title":"Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel","volume":"650","author":"Long","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jgr.2026.101073_bib129","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/aps.2013.69","article-title":"Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo","volume":"34","author":"Shi","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jgr.2026.101073_bib130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/tox.22899","article-title":"Ginsenoside Rg3 attenuates the osimertinib resistance by reducing the stemness of non-small cell lung cancer cells","volume":"35","author":"Tan","year":"2020","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.jgr.2026.101073_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22480","article-title":"Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling","volume":"34","author":"Zou","year":"2020","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jgr.2026.101073_bib132","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/cas.13881","article-title":"20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma","volume":"110","author":"Chen","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jgr.2026.101073_bib133","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/cbin.12123","article-title":"Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells","volume":"48","author":"Zhao","year":"2024","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jgr.2026.101073_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25214905","article-title":"Anti-Angiogenic properties of ginsenoside Rg3","volume":"25","author":"Nakhjavani","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jgr.2026.101073_bib135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10565-025-10091-x","article-title":"Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERalpha\/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models","volume":"41","author":"Chen","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.jgr.2026.101073_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20075-0","article-title":"Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma","volume":"12","author":"Hwang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgr.2026.101073_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2023.10.023","article-title":"Ginsenoside Rg3 endows liposomes with prolonged blood circulation and reduced accelerated blood clearance","volume":"364","author":"Xia","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.jgr.2026.101073_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj1262","article-title":"Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches","volume":"8","author":"Xia","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.jgr.2026.101073_bib139","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178617","article-title":"Rg3-lipo biomimetic delivery of paclitaxel enhances targeting of tumors and myeloid-derived suppressor cells","volume":"134","author":"Shen","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jgr.2026.101073_bib140","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2024.2324716","article-title":"Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2","volume":"31","author":"Ao","year":"2024","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jgr.2026.101073_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106352","article-title":"Saponins and their derivatives: potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance","volume":"182","author":"Qu","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jgr.2026.101073_bib142","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.phymed.2015.06.010","article-title":"Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt","volume":"22","author":"Wang","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101073_bib143","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/jpp\/rgad070","article-title":"Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR\/HIF-1alpha\/VEGF and EMT signalling pathways","volume":"75","author":"Zeng","year":"2023","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib144","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1039\/D4BM00159A","article-title":"Bioinspired ginsenoside Rg3 PLGA nanoparticles coated with tumor-derived microvesicles to improve chemotherapy efficacy and alleviate toxicity","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomater Sci"},{"key":"10.1016\/j.jgr.2026.101073_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156425","article-title":"Ginsenoside Rh2(S) maintains cytoskeleton homeostasis and inhibits pyroptosis to resist cisplatin-induced cardiotoxicity through FGFR1\/HRAS axis","volume":"138","author":"Teng","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jgr.2026.101073_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051244","article-title":"Ginsenoside Rh2 ameliorates doxorubicin-induced senescence bystander effect in breast carcinoma cell MDA-MB-231 and normal epithelial cell MCF-10A","volume":"20","author":"Hou","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgr.2026.101073_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13246","article-title":"Ginsenoside Rh2 mitigates doxorubicin-induced cardiotoxicity by inhibiting apoptotic and inflammatory damage and weakening pathological remodelling in breast cancer-bearing mice","volume":"55","author":"Hou","year":"2022","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jgr.2026.101073_bib148","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.fct.2011.06.020","article-title":"Antioxidant effects of Panax ginseng C.A. Meyer in healthy subjects: a randomized, placebo-controlled clinical trial","volume":"49","author":"Kim","year":"2011","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.jgr.2026.101073_bib149","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jep.2014.04.051","article-title":"Antioxidative effects of Korean red ginseng in postmenopausal women: a double-blind randomized controlled trial","volume":"154","author":"Seo","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jgr.2026.101073_bib150","first-page":"64","article-title":"[Effect of adjuvant chemotherapy of ginsenoside Rg3 combined with mitomycin C and tegafur in advanced gastric cancer]","volume":"10","author":"Chen","year":"2007","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"10.1016\/j.jgr.2026.101073_bib151","first-page":"2172","article-title":"Ginsenoside Rg3 inhibits HIF-1alpha and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K\/Akt and ERK1\/2 pathways","volume":"7","author":"Zeng","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jgr.2026.101073_bib152","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11655-007-9002-6","article-title":"Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer","volume":"14","author":"Lu","year":"2008","journal-title":"Chin J Integr Med"},{"key":"10.1016\/j.jgr.2026.101073_bib153","doi-asserted-by":"crossref","first-page":"70535","DOI":"10.18632\/oncotarget.12059","article-title":"Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jgr.2026.101073_bib154","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2016150719","article-title":"Prospective Study of transcatheter arterial chemoembolization (TACE) with ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma","volume":"280","author":"Zhou","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jgr.2026.101073_bib155","article-title":"The efficacy of ginsenoside Rg3 combined with first-line chemotherapy in the treatment of advanced non-small cell lung cancer in China: a systematic review and meta-analysis of randomized clinical trials","volume":"11","author":"Peng","year":"2020","journal-title":"Front Pharmacol"}],"container-title":["Journal of Ginseng Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845326000990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1226845326000990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:19:15Z","timestamp":1788225555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1226845326000990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":155,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1226845326000990"],"URL":"https:\/\/doi.org\/10.1016\/j.jgr.2026.101073","relation":{},"ISSN":["1226-8453"],"issn-type":[{"value":"1226-8453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenosides Rh2 and Rg3 in first-line combination therapy: Prospects for rapid clinical translation in drug-resistant triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Ginseng Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgr.2026.101073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Korean Society of Ginseng. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101073"}}